Multiple Sclerosis Drugs Market Size & Share to Surpass $34.36 Billion by 2030 | Vantage Market Research WASHINGTON, Dec. 01, 2023 (GLOBE NEWSWIRE) -- The Global Multiple Sclerosis Drugs Market achieved a valuation of $25.90 Billion in 2022 and is anticipated to exceed $34.36 Billion by 2030,...

Multiple Sclerosis (MS) Drugs Market Size to Hit Sales of $31.2 Bn by 2028 | Biogen, Novartis, and Roche Hold Over 55% Share of Multiple Sclerosis Drugs WASHINGTON, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Global multiple sclerosis drugs market size was $25.1 Billion in 2021 and is estimated to generate revenue of $31.2 Billion by 2028 at a CAGR of 3.7%...